Skip to main content
FinSpry Logo
FinSpry
SRPT logo
SRPT
(NASDAQ)
Sarepta Therapeutics, Inc.
$15.88-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Sarepta Therapeutics (SRPT) Stock Price & Financial Analysis

Sarepta Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$15.43 - $16.02
52-Week High$25.32
52-Week Low$10.42
Open$15.57
Volume2.48M
Average Volume (3M)3.58M
Market Cap1.93B
Shares Outstanding121.92M
P/E Ratio (TTM)32.29
Price to Sales (P/S)0.96
Price to Book (P/B)1.40
EV/EBITDA16.22
Revenue (TTM)2.18B
Net Income (TTM)65.06M
Free Cash Flow (TTM)106.14M
EPS (TTM)$0.60
Profit Margin2.98%
Operating Margin-1.88%
Return on Equity (ROE)4.32%
Debt to Equity0.69
50-Day MA$17.61
200-Day MA$19.73
52-Week Change-21.57%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Sarepta Therapeutics

What is the current stock price for SRPT?

As of the latest trading session, SRPT stock trades at $15.88. The 52-week range is $10.42–$25.32, with a day range of $15.43–$16.02.

What is the P/E ratio for SRPT?

Sarepta Therapeutics's trailing P/E ratio is 32.3, meaning investors pay $32.3 for every $1 of annual earnings. Sarepta Therapeutics operates in the Healthcare sector.

Does SRPT pay dividends?

Sarepta Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SRPT?

Based on 19 analysts, the consensus for SRPT is Buy.

What is the market cap of SRPT?

Sarepta Therapeutics's market capitalization is $1.94B, classifying it as a small-cap company. Sarepta Therapeutics operates in the Healthcare sector within the Biotechnology industry.